Literature DB >> 21686556

Herb-related aneuploidy in breast fibroadenoma.

Chun-Ju Chang1, Jen-Hwey Chiu, Chew-Wun Wu, Wing-Yu Lui.   

Abstract

There is consensus that attitudes toward seeking complementary and alternative medicine (CAM) are different between oriental and western patients. A 16-year-old girl who presented with enlarged breast tumours also had a 3-year history of "Si-Wu-Tang" (SWT) intake. Pathology of the resected breast tumour disclosed a giant fibroadenoma with aneuploid status. A cohort study was conducted between two groups of patients with fibroadenomas: SWT intake (+) group and SWT intake (-) group. Patients were told to discontinue SWT intake for 3 months, and this was followed by breast ultrasonographic examination in both groups. The tumour sizes before and after discontinued SWT intake were 2.3±0.11 cm and 1.5±0.12 cm in the SWT (+) group, and 1.7±0.15 cm and 1.6±0.14 cm in SWT (-) group, respectively (p<0.05). It is concluded that this report provides important information for patients with breast tissue diseases and that continuous intake of medicinal herbs is recommended only under the guidance of trained CAM providers.

Entities:  

Year:  2009        PMID: 21686556      PMCID: PMC3027837          DOI: 10.1136/bcr.09.2008.0926

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Si-Wu-Tang and its constituents promote mammary duct cell proliferation by up-regulation of HER-2 signaling.

Authors:  Chun-Ju Chang; Jen-Hwey Chiu; Ling-Ming Tseng; Chuan-Hsiung Chang; Tsu-Ming Chien; Chien-Chih Chen; Chew-Wun Wu; Wing-Yiu Lui
Journal:  Menopause       Date:  2006 Nov-Dec       Impact factor: 2.953

2.  Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells.

Authors:  C J Chang; J H Chiu; L M Tseng; C H Chang; T M Chien; C W Wu; W Y Lui
Journal:  Eur J Clin Invest       Date:  2006-08       Impact factor: 4.686

Review 3.  Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.

Authors:  Mark Messina; Worta McCaskill-Stevens; Johanna W Lampe
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

4.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

5.  Global gene expression profiles induced by phytoestrogens in human breast cancer cells.

Authors:  Ramiro Dip; Sarah Lenz; Jean-Philippe Antignac; Bruno Le Bizec; Hans Gmuender; Hanspeter Naegeli
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

6.  Trends in use of complementary and alternative medicine by US adults: 1997-2002.

Authors:  Hilary A Tindle; Roger B Davis; Russell S Phillips; David M Eisenberg
Journal:  Altern Ther Health Med       Date:  2005 Jan-Feb       Impact factor: 1.804

  6 in total
  1 in total

1.  Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claims.

Authors:  Bih-Ru Wang; Yuh-Lih Chang; Tzeng-Ji Chen; Jen-Hwey Chiu; Jing Chong Wu; Min-Shan Wu; Chia-Lin Chou; Yueh-Ching Chou
Journal:  Patient Prefer Adherence       Date:  2014-05-07       Impact factor: 2.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.